In prostate cancer patients, using quantitative SPECT at ~ 48 h after 177Lu-PSMA-I&T RPT, we found that body habitus and renal function were both significantly and negatively correlated with specific absorbed dose estimates for the bone marrow and the kidney [14]. Here, FOLH1 is linked to prostate cancer.